Cadmium and metallothionein levels in the liver of humans exposed to environmental cadmium in Upper Silesia, Poland

Species variation in hepatic metallothionein

Metallothionein (MT) is a low-molecular-weight protein involved in the homeostasis of endogenous metals and in the detoxication of heavy metals. In humans, the levels of hepatic MT have been shown to be up to 100 times the levels found in rat and mouse liver. In order to further investigate this species difference in hepatic MT levels, hepatic MT was quantified in 15 species (human, monkey, dog, cat, cow, pig, sheep, goat, rabbit, chicken, hamster, rat, mice, guinea pig, and frog). Fresh liver was obtained from each species and MT was quantified by 2 different metal-saturation assays. Results from the Cd-heme and Ag-heme assays showed that human, dog, cat, pig, and goat had the highest hepatic MT levels (400-700 micrograms/g liver). Monkey, cow, and sheep had moderate hepatic MT levels (about 200 micrograms/g liver), while rodents (mouse, rat, hamster, guinea pig, and rabbit) had low hepatic MT levels (2-10 micrograms/g liver). Hepatic MT levels in non-mammals (chick and frog) were slightly higher than rodents (about 20 micrograms/g liver). Sephadex G-75 column elution volumes ranged from 1.7 to 1.8, which implies that MT from all species had approximately the same molecular weight and similar structure. Copper and zinc concentration in the cytosols were measured by atomic absorption spectrophotometry. Dog and cat had the highest levels of Cu (86 and 50 micrograms/g liver, respectively), and pig and hamster were lowest (about 10 micrograms/g liver). Human, dog, cat, and goat had the highest levels of zinc (approximately 40-50 micrograms/g liver) while hamster and guinea pig were lowest (approximately 15 micrograms/g liver). The results show that there is a marked species difference in hepatic MT concentrations with dog, cat, and human having the highest levels.

Cadmium, zinc, copper and metallothionein levels in the kidney and liver of humans from central Poland

Cd, Zn, Cu, and metallothionein (MT) levels have been determined in the renal cortex and liver of 70 persons who died in Lodz and its surroundings in the years 1985-1989. The mean concentrations were: 44.9±28.6 µg Cd/g, 52.0±16.7 µg Zn/g, 2.4±1.0 µg Cu/g, 0.79±0.40 µmol Hg/g, and 3.5±1.8 µg Cd/g, 66.7±30.5 µg Zn/g, 4.9±2.1 µg Cu/g, 0.50±0.38 µmol Hg/g wet tissue in renal cortex and liver, respectively, with mean age 54.0±13.8. Smokers showed 2.4 times higher levels of Cd in the renal cortex than non-smokers. The mean body burden of Cd was 33.4±17.3 mg. Smoking increases it twofold from 22.0 mg in non-smokers to 41.8 mg in smokers.

Cadmium, zinc, copper, and metallothionein levels in the kidney and liver of inhabitants of upper Silesia (Poland)

The levels of Cd, Zn, Cu and metallothionein (MT) were determined in renal cortex and liver of 75 subjects decreased in the period 1986-1989 in the area of Upper Silesia (Katowice). The mean age of the population studied was 53.6 +/- 14.6 years. The determined levels (mean +/- SD) were: 43.1 +/- 23.5 micrograms Cd/g; 52.5 +/- 17.4 micrograms Zn/g; 2.2 +/- 0.7 microgram Cu/g; 0.80 +/- 0.36 mumol Hg/g in renal cortex and 3.5 +/- 2.5 micrograms Cd/g; 82.8 +/- 34.3 micrograms Zn/g; 4.5 +/- 2.6 micrograms Cu/g; 0.69 +/- 0.44 mumol Hg/g in the liver. The level of Cd in renal cortex was 40% higher in smokers compared to nonsmokers and was independent of the gender. Whole-body retention of Cd was 34.1 +/- 18.5 mg; smoking elevated the value from 27.1 to 38.2 mg. Compared with a similar study made in central Poland (Lódź), a significant difference was found only regarding the level of Zn and MT in the liver, pointing to the possibility that exposure to this element in the region of Upper Silesia may be higher.

Effect of cadmium on blood glucose level in the rat

The purpose of this study was to determine the effect of cadmium (Cd) or Cd and selenium (Se) administered simultaneously on plasma glucose level. Male Sprague-Dawley derived rats (180-300 g), maintained under controlled environmental conditions, were segregated into fed and 24-h fasted groups prior to experimentation. Each group consisted of 3 subgroups which received one of the following treatments intraperitoneally: sodium acetate (NaAc) (1.23 mg/kg), Cd (0.84 mg/kg) or a combination of Se and Cd (1.6 and 0.84 mg/kg respectively). Plasma glucose was measured before and 30, 60, 120, 180, 240, 300 or 360 min after treatment. Results indicate that both Cd and concurrent administration of Se and Cd induce hyperglycemia in fed and fasted rats.